Macleod Pharmaceuticals Information

Headquartered in Ft. Collins, Colorado, Macleod Pharmaceuticals, Inc. provides products for an international customer base. Macleods primary focus is on animal health, an expanding market throughout the world. The company is the exclusive marketer for INTRACELL, an all-species wound management product. The company has come a long way since it was founded by its owner, Dr. Mike Pay, in 1989. Starting out as a subsidiary of a British veterinary pharmaceutical company, it became an American based corporation in 1991 when Dr. Pay, sold the British half of the company and moved the remaining operations to Colorado. Macleod has always maintained one underlying motive: a passion for animals and a desire to address their complex health problems. Macleod Pharmaceuticals, Inc. obtained its first FDA approval in 1993 for UNIPRIM® Powder, an equine product for fighting bacterial infections. It maintains its own in-house research and production facilities as well as off-site manufacturing capabilities through approved sub-contracting facilities. Macleods current product emphasis is on UNIPRIM® Powder For Horses and INTRACELL, and has a number of animal health products in varying stages of FDA approval.